Search
Close this search box.

What Happened to the Flu and RSV?

Wash your hands. Cover your nose. It’s familiar advice, but in the wake of a global pandemic, more people seem to be following it.

Sixth Annual Infant Health Policy Summit

The sixth annual Infant Health Policy Summit welcomed health care providers, parents, policymakers, advocates and other stakeholders to explore how policy solutions can improve the health and lives of infants and their families. This year’s event, held virtually, examined issues such as: Late preterm infants Respiratory syncytial virus and COVID-19 Isolation and disruption during COVID-19 […]

RSV: National Report Card

A national data supplier provided palivizumab claims for Medicaid and commercial health plans across the nation from January 2019 through December 2019. Health plans deny 40% of palivizumab prescriptions for premature infants born between 29 and 36 weeks gestation. One in every four prescriptions is denied for infants who should qualify for coverage under standard […]

40% of Babies Denied Preventive Treatment by Insurers

Parents of premature babies face enough challenges. Trying to access medication that could keep their baby safe from respiratory syncytial virus, a potentially deadly disease, shouldn’t be one of them. But new national data shows that’s the case.

Human Milk’s “Secret Ingredients”

Researchers may have pinpointed the “secret ingredients” that allow human milk to protect newborns against a life-threatening condition called necrotizing enterocolitis. They are HMOs – human milk oligosaccharides.